{
  "id": 1387,
  "text": "$ $\\mathrm { p } \\leq 0 .0 5 )$ .Corrado et al.1229 compared the surgical and oncological results of robotic surgery with a historical cohort of patients undergoing laparoscopic or abdominal hysterectomy plus pelvic lymphadenectomy for LACC after NACT.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: $ $\\mathrm { p } \\leq 0 .0 5 )$ .Corrado et al.1229 compared the surgical and oncological results of robotic surgery with a historical cohort of patients undergoing laparoscopic or abdominal hysterectomy plus pelvic lymphadenectomy for LACC after NACT.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "基于可得信息，不同术式治疗宫颈癌显示出各自的优势和适应症。机器人辅助手术通常因其高精确度、较低的术后并发症率和较快的恢复时间而被认为具有明显优势。然而，与腹腔镜手术或腹部子宫切除术联合骨盆淋巴结切除术相比，机器人辅助手术在手术时间、成本等方面可能有所不同。\n\n从肿瘤学疗效来看，研究表明机器人辅助手术在术后切缘阳性率、局部复发率和总体生存率方面可能与传统的腹腔镜或开腹手术相当。然而，具体疗效取决于患者的肿瘤分期、术前治疗（如新辅助化疗）的应用以及术者技术熟练程度。\n\n因此，对于局部晚期宫颈癌（LACC）患者，在接受新辅助化疗（NACT）后的具体术式选择应根据患者的实际情况，如肿瘤分期、解剖特征和全身情况，由医疗团队综合评估后决定。\n\n",
  "query": "可以对不同术式治疗宫颈癌的效果进行对比吗？比如机器人辅助手术与腹腔镜或腹部子宫切除术结合骨盆淋巴结切除术的效果如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 可以对不同术式治疗宫颈癌的效果进行对比吗？比如机器人辅助手术与腹腔镜或腹部子宫切除术结合骨盆淋巴结切除术的效果如何？\n\n<reference text>: $ $\\mathrm { p } \\leq 0 .0 5 )$ .Corrado et al.1229 compared the surgical and oncological results of robotic surgery with a historical cohort of patients undergoing laparoscopic or abdominal hysterectomy plus pelvic lymphadenectomy for LACC after NACT.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "基于可得信息，不同术式治疗宫颈癌显示出各自的优势和适应症。机器人辅助手术通常因其高精确度、较低的术后并发症率和较快的恢复时间而被认为具有明显优势。然而，与腹腔镜手术或腹部子宫切除术联合骨盆淋巴结切除术相比，机器人辅助手术在手术时间、成本等方面可能有所不同。\n\n从肿瘤学疗效来看，研究表明机器人辅助手术在术后切缘阳性率、局部复发率和总体生存率方面可能与传统的腹腔镜或开腹手术相当。然而，具体疗效取决于患者的肿瘤分期、术前治疗（如新辅助化疗）的应用以及术者技术熟练程度。\n\n因此，对于局部晚期宫颈癌（LACC）患者，在接受新辅助化疗（NACT）后的具体术式选择应根据患者的实际情况，如肿瘤分期、解剖特征和全身情况，由医疗团队综合评估后决定。\n\n"
}